Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HBB | P68871 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | P2RX4 | Q99571 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20437404 | 0.91 | MAPT (0.36) | MAPTMEN1LMNACYP1A2CYP2C9 | |
| SCHEMBL20437411 | 0.86 | MAPT (0.36) | MAPTMEN1LMNACYP1A2CYP2C9 | |
| SCHEMBL20437403 | 0.83 | KDM4E (0.36) | MAPTMEN1LMNACYP1A2CYP2C9 | |
| SCHEMBL19344958 | 0.82 | KDM4E (0.38) | MAPTMEN1LMNACYP1A2CYP2C9 | |
| SCHEMBL17954518 | 0.82 | KDM4E (0.39) | MAPTMEN1LMNACYP1A2CYP2C9 | |
| SCHEMBL19345079 | 0.82 | CA1 (0.35) | LMNAKDM4EP2RX4 | |
| SCHEMBL17954901 | 0.81 | ESR2 (0.39) | MAPK1KDM4EP2RX4 | |
| SCHEMBL19340279 | 0.81 | KDM4E (0.36) | MAPTMEN1LMNACYP1A2CYP2C9 | |
| SCHEMBL20277003 | 0.81 | TRPA1 (0.38) | MAPTMEN1LMNACYP1A2CYP2C9 | |
| SCHEMBL20061233 | 0.81 | P2RX4 (0.35) | P2RX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3288956-B1 | LIGHT EMITTING DEVICES AND COMPOUNDS | UNIV COURT UNIV ST ANDREWS (GB) | 2020-12-23 | — | — | EP | disclosed |
| US-20180123052-A1 | LIGHT EMITTING DEVICES AND COMPOUNDS | UNIV COURT UNIV ST ANDREWS (GB) | 2018-05-03 | — | — | US | disclosed |
| WO-2016174377-A1 | LIGHT EMITTING DEVICES AND COMPOUNDS | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2016-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180123052-A1 | LIGHT EMITTING DEVICES AND COMPOUNDS | DDC, TRPC1, TRPC4 | MAPT 3156/4885MEN1 3576/4885LMNA 1279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.